Selected Grants
Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE)
Clinical TrialCo Investigator · Awarded by University of Maryland, Baltimore · 2022 - 2027A Clinical Trial Readiness Study of Patient Reported Outcome Measures in Thrombotic Thrombocytopenic Purpura (TTP)
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2026Increasing Diversity in Clinical Trials Participation through the SCD-CARRE Study
ResearchPrincipal Investigator · Awarded by Bristol-Myers Squibb Foundation · 2023 - 2026Developing apheresis-specific outcomes to facilitate a multi-center study of therapeutic plasma exchange in heparin-induced thrombocytopenia
ResearchPrincipal Investigator · Awarded by Robert Wood Johnson Foundation · 2020 - 2024Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE)
Clinical TrialCo Investigator · Awarded by University of Pittsburgh · 2020 - 2022American Society for Apheresis (ASFA) Heparin Induced Thrombocytopenia Registry
ResearchPrincipal Investigator · Awarded by American Society for Apheresis · 2019 - 2020Defining the role of therapeutic plasma exchange in heparin induced thrombocytopenia
ResearchPrincipal Investigator · Awarded by Hemophilia & Thrombosis Research Society · 2017 - 2020Core Clinical Centers for the CTSN
ResearchCo Investigator · Awarded by National Institutes of Health · 2007 - 2018Cellular Basis of HIT Immune Response in Cardiac Surgery
ResearchPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2012 - 2017Population-based Surveillance And Outcomes of Venous Thromboembolism
ResearchCo Investigator · Awarded by Centers for Disease Control and Prevention · 2012 - 2015External Relationships
- Coag Coach LLC
- Sanofi
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.